Nancy J Brown Selected Research

Mineralocorticoid Receptors (Mineralocorticoid Receptor)

1/2019	Mineralocorticoid Receptor Activation and Atrial Fibrosis.
8/2013	Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.
10/2012	Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery.
9/2012	Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
1/2011	This is not Dr. Conn's aldosterone anymore.
6/2010	Aldosterone and inflammation.
5/2009	Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
12/2006	Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism.
5/2005	Aldosterone and end-organ damage.
5/2003	Eplerenone: cardiovascular protection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nancy J Brown Research Topics

Disease

43	Hypertension (High Blood Pressure) 01/2023 - 03/2002
17	Insulin Resistance 10/2023 - 08/2002
13	Inflammation (Inflammations) 01/2023 - 05/2005
13	Angioedema 12/2020 - 02/2002
12	Fibrosis (Cirrhosis) 01/2019 - 05/2002
11	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 10/2005
10	Obesity 10/2023 - 02/2004
10	Heart Failure 01/2022 - 05/2003
8	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2012
8	Thrombosis (Thrombus) 11/2018 - 12/2003
7	Atrial Fibrillation 01/2018 - 09/2007
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017 - 09/2007
5	Prediabetic State (Prediabetes) 01/2024 - 12/2015
5	Hypotension (Low Blood Pressure) 11/2023 - 11/2005
5	Weight Loss (Weight Reduction) 10/2023 - 01/2018
5	Myocardial Infarction 11/2018 - 12/2002
5	Essential Hypertension 12/2011 - 03/2002
4	Body Weight (Weight, Body) 01/2023 - 02/2004
4	Hyperglycemia 01/2018 - 02/2004
4	Acute Kidney Injury (Acute Renal Failure) 07/2016 - 12/2010
3	Overweight 01/2023 - 01/2010
3	Albuminuria 09/2012 - 09/2007
3	Vascular Remodeling 10/2010 - 06/2002
3	Edema (Dropsy) 09/2010 - 08/2007
2	Neoplasms (Cancer) 01/2023 - 09/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2021 - 10/2015
2	Hyperaldosteronism (Conn Syndrome) 01/2021 - 09/2007
2	Pathologic Processes 01/2020 - 09/2005
2	Hypertriglyceridemia 11/2018 - 10/2016
2	Hemorrhage 11/2018 - 01/2011
2	Diabetes Mellitus 01/2018 - 08/2014
2	Drug-Related Side Effects and Adverse Reactions 09/2017 - 09/2013
2	Ischemia 01/2017 - 05/2012
2	Chronic Renal Insufficiency 01/2017 - 03/2016

Drug/Important Bio-Agent (IBA)

19	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020 - 02/2002
18	Plasminogen Activator Inhibitor 1IBA 01/2023 - 05/2002
16	AldosteroneIBA 10/2014 - 05/2002
15	SaltsIBA 07/2014 - 03/2004
12	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 10/2004
12	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 05/2002
11	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 05/2002
11	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2017 - 04/2004
10	BradykininIBA 11/2018 - 02/2002
9	Sitagliptin Phosphate (Januvia)FDA Link 10/2023 - 10/2010
7	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2024 - 09/2009
7	Peptides (Polypeptides)IBA 09/2022 - 11/2006
7	Substance PIBA 01/2017 - 02/2002
7	SodiumIBA 03/2016 - 03/2002
6	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 10/2023 - 02/2002
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2007
6	AcidsIBA 01/2022 - 10/2014
6	Proteins (Proteins, Gene)FDA Link 05/2016 - 10/2005
6	ReninIBA 10/2014 - 10/2004
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2012 - 06/2002
5	EnzymesIBA 01/2022 - 03/2002
5	Epoxide HydrolasesIBA 01/2022 - 10/2014
5	Angiotensin Receptor AntagonistsIBA 12/2020 - 09/2009
5	Ramipril (Altace)FDA LinkGeneric 10/2019 - 05/2009
5	Insulin (Novolin)FDA Link 01/2018 - 10/2004
5	Mineralocorticoid Receptor AntagonistsIBA 03/2016 - 05/2003
5	Spironolactone (Aldactone)FDA LinkGeneric 07/2014 - 05/2003
5	Angiotensin IIIBA 09/2012 - 05/2009
4	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2023 - 05/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 12/2010
4	AngiotensinsIBA 07/2011 - 10/2003
3	Bradykinin B2 ReceptorIBA 11/2023 - 11/2005
3	Liraglutide FDA Link 10/2023 - 01/2023
3	Glucagon-Like Peptide-1 ReceptorIBA 10/2023 - 01/2023
3	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 11/2005
3	CatecholaminesIBA 09/2022 - 01/2020
3	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2021 - 10/2003
3	Valsartan (Vals)FDA Link 10/2019 - 03/2007
3	Fish OilsIBA 11/2018 - 10/2013
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018 - 10/2013
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 05/2012
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2013 - 05/2009
3	PotassiumIBA 08/2013 - 11/2006
3	Messenger RNA (mRNA)IBA 09/2012 - 02/2004
3	Plasminogen InactivatorsIBA 04/2012 - 08/2002
3	2,5-dichloro-4-bromophenol (B 2)IBA 10/2009 - 11/2005
2	Hormones (Hormone)IBA 01/2023 - 05/2014
2	IncretinsIBA 01/2023 - 05/2014
2	ProstaglandinsIBA 01/2023 - 01/2017
2	CarbohydratesIBA 01/2023 - 02/2004
2	Therapeutic UsesIBA 01/2023 - 09/2017
2	Neuropeptide YIBA 09/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2016
2	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021 - 03/2016
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 03/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2018 - 01/2018
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2018 - 10/2013
2	Vasodilator Agents (Vasodilators)IBA 01/2018 - 01/2018
2	icatibantIBA 07/2017 - 10/2009
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017 - 09/2002
2	HDL LipoproteinsIBA 10/2016 - 10/2004
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2016 - 03/2016
2	Neprilysin (Neutral Endopeptidase)IBA 03/2016 - 09/2013

Therapy/Procedure

6	Renal Dialysis (Hemodialysis) 11/2023 - 10/2009
5	Therapeutics 01/2023 - 12/2010
4	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2017 - 11/2005